6-KThe Wire
Alpha Tau Medical Ltd. files 6-K
Filed Dec 9, 2025 · 7mo ago · Accession 0001213900-25-119461
Plain English
Alpha Tau Medical Ltd. announced the successful treatment of the first patient in its U.S. trial for recurrent glioblastoma at The Ohio State University. This marks a significant step in the company's clinical development for this indication.
Filing details
- Company
- Alpha Tau Medical Ltd.
- Ticker
- DRTS
- CIK
- 1871321
- Form type
- 6-K
- Filing date
- Dec 9, 2025
- Report date
- Dec 9, 2025
- Document
- ea0268912-6k_alpha.htm
- Size
- 29 KB